{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T22:25:01Z","timestamp":1769207101281,"version":"3.49.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,4,22]],"date-time":"2014-04-22T00:00:00Z","timestamp":1398124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,4,22]],"date-time":"2014-04-22T00:00:00Z","timestamp":1398124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1038\/tpj.2014.18","type":"journal-article","created":{"date-parts":[[2014,4,22]],"date-time":"2014-04-22T10:31:59Z","timestamp":1398162719000},"page":"488-492","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Association of PAX4 genetic variants with oral antidiabetic drugs efficacy in Chinese type 2 diabetes patients"],"prefix":"10.1038","volume":"14","author":[{"given":"M","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,22]]},"reference":[{"key":"BFtpj201418_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcp.2006.06.024","volume":"73","author":"D Lang","year":"2007","unstructured":"Lang D, Powell SK, Plummer RS, Young KP, Ruggeri BA . PAX genes: roles in development, pathophysiology, and cancer. Biochem Pharmacol 2007; 73: 1\u201314.","journal-title":"Biochem Pharmacol"},{"key":"BFtpj201418_CR2","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/386399a0","volume":"386","author":"B Sosa-Pineda","year":"1997","unstructured":"Sosa-Pineda B, Chowdhury K, Torres M, Oliver G, Gruss P . The Pax4 gene is essential for differentiation of insulin-producing beta cells in the mammalian pancreas. Nature 1997; 386: 399\u2013402.","journal-title":"Nature"},{"key":"BFtpj201418_CR3","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1210\/en.2004-1576","volume":"146","author":"JF Habener","year":"2005","unstructured":"Habener JF, Kemp DM, Thomas MK . Minireview: transcriptional regulation in pancreatic development. Endocrinology 2005; 146: 1025\u20131034.","journal-title":"Endocrinology"},{"key":"BFtpj201418_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jdiacomp.2012.03.025","volume":"26","author":"S Kooptiwut","year":"2012","unstructured":"Kooptiwut S, Plengvidhya N, Chukijrungroat T, Sujjitjoon J, Semprasert N, Furuta H et al. Defective PAX4 R192H transcriptional repressor activities associated with maturity onset diabetes of the young and early onset-age of type 2 diabetes. J Diabetes Compl 2012; 26: 343\u2013347.","journal-title":"J Diabetes Compl"},{"key":"BFtpj201418_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.metabol.2005.08.014","volume":"55","author":"Y Tokuyama","year":"2006","unstructured":"Tokuyama Y, Matsui K, Ishizuka T, Egashira T, Kanatsuka A . The Arg121Trp variant in PAX4 gene is associated with beta-cell dysfunction in Japanese subjects with type 2 diabetes mellitus. Meta Clin Exp 2006; 55: 213\u2013216.","journal-title":"Meta Clin Exp"},{"key":"BFtpj201418_CR6","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.2337\/diabetes.50.12.2864","volume":"50","author":"Y Shimajiri","year":"2001","unstructured":"Shimajiri Y, Sanke T, Furuta H, Hanabusa T, Nakagawa T, Fujitani Y et al. A missense mutation of Pax4 gene (R121W) is associated with type 2 diabetes in Japanese. Diabetes 2001; 50: 2864\u20132869.","journal-title":"Diabetes"},{"key":"BFtpj201418_CR7","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1210\/jc.2006-1927","volume":"92","author":"N Plengvidhya","year":"2007","unstructured":"Plengvidhya N, Kooptiwut S, Songtawee N, Doi A, Furuta H, Nishi M et al. PAX4 mutations in Thais with maturity onset diabetes of the young. J Clin Endocrinol Metab 2007; 92: 2821\u20132826.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFtpj201418_CR8","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1007\/s00125-005-1723-5","volume":"48","author":"A Biason-Lauber","year":"2005","unstructured":"Biason-Lauber A, Boehm B, Lang-Muritano M, Gauthier BR, Brun T, Wollheim CB et al. Association of childhood type 1 diabetes mellitus with a variant of PAX4: possible link to beta cell regenerative capacity. Diabetologia 2005; 48: 900\u2013905.","journal-title":"Diabetologia"},{"key":"BFtpj201418_CR9","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1093\/hmg\/ddh341","volume":"13","author":"F Mauvais-Jarvis","year":"2004","unstructured":"Mauvais-Jarvis F, Smith SB, Le May C, Leal SM, Gautier JF, Molokhia M et al. PAX4 gene variations predispose to ketosis-prone diabetes. Hum Mol Genet 2004; 13: 3151\u20133159.","journal-title":"Hum Mol Genet"},{"key":"BFtpj201418_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/ng.1019","volume":"44","author":"YS Cho","year":"2012","unstructured":"Cho YS, Chen CH, Hu C, Long J, Ong RT, Sim X et al. Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat Genet 2012; 44: 67\u201372.","journal-title":"Nat Genet"},{"key":"BFtpj201418_CR11","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1007\/s00125-013-2874-4","volume":"56","author":"RC Ma","year":"2013","unstructured":"Ma RC, Hu C, Tam CH, Zhang R, Kwan P, Leung TF et al. Genome-wide association study in a Chinese population identifies a susceptibility locus for type 2 diabetes at 7q32 near PAX4. Diabetologia 2013; 56: 1291\u20131305.","journal-title":"Diabetologia"},{"key":"BFtpj201418_CR12","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1745-7254.2008.00744.x","volume":"29","author":"J Wang","year":"2008","unstructured":"Wang J, Bao YQ, Hu C, Zhang R, Wang CR, Lu JX et al. Effects of ABCA1 variants on rosiglitazone monotherapy in newly diagnosed type 2 diabetes patients. Acta Pharmacol Sin 2008; 29: 252\u2013258.","journal-title":"Acta Pharmacol Sin"},{"key":"BFtpj201418_CR13","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1111\/j.1745-7254.2008.00840.x","volume":"29","author":"YY He","year":"2008","unstructured":"He YY, Zhang R, Shao XY, Hu C, Wang CR, Lu JX et al. Association of KCNJ11 and ABCC8 genetic polymorphisms with response to repaglinide in Chinese diabetic patients. Acta Pharmacol Sin 2008; 29: 983\u2013989.","journal-title":"Acta Pharmacol Sin"},{"key":"BFtpj201418_CR14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/clpt.2010.351","volume":"89","author":"WH Yu","year":"2011","unstructured":"Yu WH, Hu C, Zhang R, Wang CR, Qin W, Lu JY et al. Effects of KCNQ1 polymorphisms on the therapeutic efficacy of oral antidiabetic drugs in Chinese patients with type 2 diabetes. Clin Pharmacol Ther 2011; 89: 437\u2013442.","journal-title":"Clin Pharmacol Ther"},{"key":"BFtpj201418_CR15","first-page":"104","volume":"36","author":"YY Bao","year":"2007","unstructured":"Bao YY, Jia WP, Gao X, Liu W, Xing HL, Liu ZM et al. Evaluation of insulin secretion and insulin sensitivity in the selection of hypoglycemic drugs\u2014a multicentre clinical study. Chin J Endocrinol Metab 2007; 36: 104\u2013109.","journal-title":"Chin J Endocrinol Metab"},{"key":"BFtpj201418_CR16","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412\u2013419.","journal-title":"Diabetologia"},{"key":"BFtpj201418_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ejim.2006.09.007","volume":"18","author":"JW Elte","year":"2007","unstructured":"Elte JW, Blickle JF . Thiazolidinediones for the treatment of type 2 diabetes. Eur J Intern Med 2007; 18: 18\u201325.","journal-title":"Eur J Intern Med"},{"key":"BFtpj201418_CR18","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/S0140-6736(00)90002-3","volume":"355","author":"K Schoonjans","year":"2000","unstructured":"Schoonjans K, Auwerx J . Thiazolidinediones: an update. Lancet 2000; 355: 1008\u20131010.","journal-title":"Lancet"},{"key":"BFtpj201418_CR19","first-page":"683","volume":"51","author":"J Noble","year":"2005","unstructured":"Noble J, Baerlocher MO, Silverberg J . Management of type 2 diabetes mellitus. Role of thiazolidinediones. Can Fam Physician 2005; 51: 683\u2013687.","journal-title":"Can Fam Physician"},{"key":"BFtpj201418_CR20","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1210\/jcem.86.1.7157","volume":"86","author":"HE Lebovitz","year":"2001","unstructured":"Lebovitz HE, Dole JF, Patwardhan R, Rappaport EB, Freed MI . Rosiglitazone monotherapy is effective in patients with type 2 diabetes. J Clin Endocrinol Metab 2001; 86: 280\u2013288.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFtpj201418_CR21","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.2165\/00003495-200767180-00008","volume":"67","author":"ED Deeks","year":"2007","unstructured":"Deeks ED, Keam SJ . Rosiglitazone: a review of its use in type 2 diabetes mellitus. Drugs 2007; 67: 2747\u20132779.","journal-title":"Drugs"},{"key":"BFtpj201418_CR22","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.bbrc.2007.12.192","volume":"367","author":"HS Kim","year":"2008","unstructured":"Kim HS, Noh JH, Hong SH, Hwang YC, Yang TY, Lee MS et al. Rosiglitazone stimulates the release and synthesis of insulin by enhancing GLUT-2, glucokinase and BETA2\/NeuroD expression. Biochem Biophys Res Commun 2008; 367: 623\u2013629.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFtpj201418_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2337\/db06-0948","volume":"56","author":"JA Moibi","year":"2007","unstructured":"Moibi JA, Gupta D, Jetton TL, Peshavaria M, Desai R, Leahy JL . Peroxisome proliferator-activated receptor-gamma regulates expression of PDX-1 and NKX6.1 in INS-1 cells. Diabetes 2007; 56: 88\u201395.","journal-title":"Diabetes"},{"key":"BFtpj201418_CR24","doi-asserted-by":"publisher","first-page":"32462","DOI":"10.1074\/jbc.M801813200","volume":"283","author":"D Gupta","year":"2008","unstructured":"Gupta D, Jetton TL, Mortensen RM, Duan SZ, Peshavaria M, Leahy JL . In vivo and in vitro studies of a functional peroxisome proliferator-activated receptor gamma response element in the mouse pdx-1 promoter. J Biol Chem 2008; 283: 32462\u201332470.","journal-title":"J Biol Chem"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tpj201418.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tpj201418","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tpj201418.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T10:39:43Z","timestamp":1647945583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tpj201418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,22]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["BFtpj201418"],"URL":"https:\/\/doi.org\/10.1038\/tpj.2014.18","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,22]]},"assertion":[{"value":"2 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}